Dover Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 7% year-over-year with all segments posting organic growth and adjusted EPS up 12%. Bookings rose 16% and the book-to-bill ratio remained strong at 1.06, supporting a raised full-year EPS outlook. Secular growth markets and capacity expansions are driving future momentum.
-
Q1 2026 saw double-digit revenue growth and record bookings, with strong performance in Clean Energy, Climate, and Engineered Products segments. Adjusted EPS rose 11% year-over-year, and full-year guidance was reaffirmed, with robust demand and a healthy order book supporting a positive outlook.
-
Guidance remains unchanged with strong order trends and robust backlogs, especially in CO2 and Clean Energy & Fueling. Margin targets are ambitious, supported by restructuring and pricing power, while capital allocation is balanced between M&A and buybacks. North America focus and a strong balance sheet underpin resilience.
-
Order acceleration and a strong backlog set up positive growth for 2026, led by Clean Energy and Climate & Sustainability segments. Portfolio optimization and disciplined M&A support margin improvement, while stable pricing and targeted investments drive long-term growth.
Fiscal Year 2025
-
Fourth quarter 2025 delivered strong organic growth, margin expansion, and robust free cash flow, with all segments showing bookings growth and double-digit EPS gains. 2026 guidance calls for continued double-digit EPS growth, strong cash conversion, and further productivity and M&A benefits.
-
Organic growth is set to peak in Q4, with strong margin conversion and improved cash flow driven by margin mix. Capital allocation is balanced between M&A and buybacks, with growth platforms in turbines, AI, and retail fueling poised for multi-year expansion.
-
Portfolio strategy emphasizes ROIC, strategic M&A, and divestitures at strong multiples. Margin expansion continues with cost actions and synergy extraction, targeting 20% by 2026. Growth platforms in thermal connectors, CO2 systems, and clean energy components are scaling, while AI-driven operational efficiency supports further profitability.
-
Q3 saw 5% revenue growth, record 26.1% EBITDA margin, and 15% higher adjusted EPS, with all segments improving margins. Bookings rose 8% year-over-year, and full-year EPS guidance was raised. Acquisitions and productivity initiatives are fueling growth into 2026.
-
Q2 delivered strong margin and EPS growth, with bookings up 7% year-over-year and robust free cash flow. Guidance for full-year adjusted EPS was raised, supported by strong demand in growth platforms and ongoing productivity actions.
-
The event highlighted a major acquisition in precision measurement, ongoing investments in automation, and strong growth in biopharma, CO2 systems, and clean energy segments. Data center cooling and heat exchangers are poised for further expansion, with robust demand and margin improvement expected.
-
Adjusted EPS rose 19% year-over-year with record Q1 margins and strong bookings. Guidance was trimmed due to tariff and demand uncertainty, but Q2 is supported by backlog and pricing actions are in place to offset tariff costs. Secular growth markets and productivity initiatives continue to drive performance.
-
Order rates and backlog remain strong across key segments, with double-digit growth in CO2 systems and biopharma. Margin expansion is driven by restructuring and portfolio actions, while disciplined capital allocation and flexible supply chains position the business well for 2024 and beyond.
-
Order momentum remains strong into 2025, with growth led by high-margin segments like CO2 systems and biopharma. Margin expansion is targeted through restructuring and portfolio optimization, while M&A will focus on bolt-ons in high-value niches.
Fiscal Year 2024
-
Fourth quarter delivered broad-based organic growth, margin expansion, and strong free cash flow. 2025 guidance remains robust despite FX headwinds, with double-digit EPS growth targeted and continued investment in high-growth markets and margin accretive segments.
-
Management expects improved unitary growth in 2025 as macro conditions normalize and portfolio moves drive margin expansion. Strategic focus is on organic investment, targeted M&A, and high-value segments like clean energy and biopharma, with operational improvements supporting growth.
-
Third quarter results exceeded expectations with record segment margin and strong organic bookings growth. Portfolio rotation and divestitures have positioned the company for higher-margin growth in 2025, with robust capital deployment capacity and a constructive outlook for the year ahead.
-
Q2 delivered 5% organic revenue growth, 200 bps margin expansion, and strong bookings, with four of five segments growing. Portfolio actions included two clean energy acquisitions and the $2B ESG sale, supporting a raised EPS outlook and robust capital deployment capacity.